TSC2 and acute myeloid leukemia: While single drug inhibition of NF-κB showed little long-term effectiveness to repress anchorage-independent growth of TSC2(−) AML cells, we observed marked reduction of colony size with combined treatment with NF-κB/mTOR inhibitors, which persisted after removal of both drugs.